All In Biotech

Drug Trial Radar · NCT04243837

LYT-100 in Patients With BCRL

A Phase 2a Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of Deupirfenidone (LYT-100) in Patients With Breast Cancer-Related Upper Limb Secondary Lymphoedema

Last checked: Nov 20, 2026Latest source record: Apr 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

50

Actual

Start

Mar 1, 2020

Primary completion

Sep 9, 2022

Study completion Sep 9, 2022

Sponsor

Lead sponsor
PureTechIndustry
Sponsor type
Industry
Collaborators
Novotech (Australia) Pty Limited
First posted
Jan 28, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a trial of up to 6-months duration for safety, tolerability, clinical efficacy assessments, PK and biomarkers analysis in breast carcinoma patients with secondary lymphoedema

Conditions

  • Breast Cancer Related Lymphoedema
  • Lymphoedema

Interventions

  • LYT-100 BCRLDrug

    BCRL patients will receive LYT-100 BID for 6 months

  • Placebo BCRLDrug

    BCRL patients will receive Placebo BID for 6 months

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and Tolerability: Number of Participants With Treatment-emergent Adverse Events (TEAEs)Time frame: 6 months

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • City of Hope National Medical Center

    Duarte, California

  • MACRO Trials

    Los Angeles, California

  • Accel Research Network

    Maitland, Florida

  • Accel Research Network

    Atlanta, Georgia

  • Flinders University

    Adelaide, Australia

  • Macquarie University Health Sciences Centre

    Sydney, Australia

  • University of the Sunshine Coast

    Sippy Downs, Queensland, Australia

  • Ballarat Health Services

    Ballarat, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.